Astrazeneca Company News

Epic Code:
Sub Sector:
Market Cap:

Pharmaceuticals & Biotechnology
UK Main Market
41446.4387748 GBPm

Data as of 10:00 23/09/2009. Check director details and other company announcments at Astrazeneca Website .

RNS News for Astrazeneca

Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.

Latest Astrazeneca News

AstraZeneca PLC (LSE:AZN): Can It Deliver A Superior ROE To The Industry?
Simply Wall St - 26 minutes ago
AstraZeneca PLC (LSE:AZN) generated a below-average return on equity of 24.48% in the past 12 months, while its industry returned 38.53%.
AstraZeneca PLC (AZN.L) Needle Moving on Volume - Clayton News
Investor Outlook: AstraZeneca PLC (LON:AZN) Hold Rating Reconfirmed by Shore ... - WeeklyHub

08/18/2017 02:52 PM

AstraZeneca ovarian cancer drug approved for wider use
Proactive Investors UK - 7 hours ago
American regulators have given the green light for the wider usage of an ovarian cancer drug. Sold by AstraZeneca PLC (LON:AZN) and Merck & Co Inc (NYSE:MRK), Lynparza will now be prescribed to patients with recurrent ovarian cancer who have ...
TOP NEWS: AstraZeneca Gets US Approval For Tablet Form Of Lynparza - Interactive Investor
AstraZeneca, Time To Expand The Operation - Seeking Alpha

08/18/2017 07:33 AM

FDA expands use of AstraZeneca/Merck ovarian cancer drug
Reuters - 17 hours ago
(Reuters) - The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing treatment of patients with recurrent ovarian cancer who have responded to platinum-based ...

08/17/2017 09:43 PM

FDA approves expanded use of AstraZeneca ovarian cancer drug
Reuters UK - 17 hours ago
(Reuters) - The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc (AZN.L) and Merck & Co Inc (MRK.

08/17/2017 09:37 PM

Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for August 09, 2017
Nasdaq - Aug 8, 2017
Astrazeneca PLC ( AZN ) will begin trading ex-dividend on August 09, 2017. A cash dividend payment of $0.44 per share is scheduled to be paid on September 11, 2017.
Earnings Analysis Of AstraZeneca PLC (AZN) - ExpressNewsline
AstraZeneca plc (AZN) Rating Reiterated by Barclays PLC - BNB Daily (blog)

08/08/2017 02:07 PM

Why I'm not buying FTSE 100 giants AstraZeneca plc and Barclays plc for their ...
Motley Fool UK - Aug 5, 2017
Healthcare giant AstraZeneca (LSE: AZN) made the headlines recently after it announced on the 27 July that results of its Mystic drug study showed a combination of two injectable immuno-therapies, Imfinzi (durvalumab) and tremelimumab, was no more ...

08/05/2017 07:33 AM